Parotid Gland Enlargement in Children Post-Vaccination
Diagnostic Considerations
- The American Academy of Pediatrics suggests that in a child with unilateral parotid enlargement who has received MMR vaccination, the most likely diagnosis is either vaccine-strain parotitis or wild-type mumps infection, and determining the timing of symptom onset relative to vaccination is critical 1
- The Centers for Disease Control and Prevention (CDC) indicates that if parotitis developed 10-14 days after MMR vaccination, this timing strongly suggests vaccine-strain parotitis, as this corresponds to peak vaccine viral replication 1
- Vaccine effectiveness is approximately 88% after two doses, and wild-type mumps infection should be considered if parotitis developed outside the 10-14 day window or with known mumps exposure 2
Clinical Features and Management
- The CDC recommends verifying the child's vaccination status, with the first MMR dose given at 12-15 months and the second dose typically given at 4-6 years 3
- For vaccine-strain parotitis, symptomatic management with acetaminophen or NSAIDs for pain and fever control is recommended 1
- The CDC advises that vaccine-strain parotitis does not transmit to others and requires no public health reporting 1
- For wild-type mumps infection, isolation precautions should be implemented for 5 days from parotitis onset with droplet precautions, and the case should be reported to the local health department as mumps is a notifiable disease 1
Complications and Monitoring
- Aseptic meningitis occurs in 4-6% of mumps cases, and orchitis can occur in up to 38% of postpubertal males 2
- Sensorineural deafness is a major complication of mumps infection, particularly in the pre-vaccine era 2
- Pancreatitis can occur as a complication of mumps infection 2
Management Pitfalls to Avoid
- The CDC advises against administering additional MMR doses in response to post-vaccination parotitis, as this represents a normal vaccine response, not vaccine failure 1
- Antivirals or antibiotics should not be used to treat vaccine-strain parotitis, as it is self-limited and resolves without specific intervention 1
- Immunity should not be assumed based on vaccination alone, as breakthrough infections can occur and two doses provide only 88% protection 2